With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

13% over the period of 2022-2028. Needle-free injection technology (NFIT) refers to a wide range of drug delivery systems that propel drugs through the skin using forces such as Lorentz, shock waves, ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...

Ozempic (semaglutide ... Another difference is that metformin is an oral medication, so it’s a good choice for people who don’t tolerate injections. Metformin can also be taken alongside ...

DOVER, Del.--(BUSINESS WIRE)--Telehealth company Henry Meds, known for its innovation in telehealth medicine and commitment to patient-centric care, announced today that it will now provide ...

Blockbuster obesity and diabetes drugs — such as Wegovy, Ozempic, and Mounjaro — are no longer deemed by regulators to be in shortage, so compounding pharmacies and the telehealth companies ...

Telehealth company Henry Meds, known for its innovation in telehealth medicine and commitment to patient-centric care, announced today that it will now provide healthcare to patients suffering ...

Fridays weight loss is a telehealth provider that offers access to popular GLP-1 medications, including compounded versions of semaglutide and tirzepatide, from the comfort of your home.